HomeCompareGAILF vs MRK

GAILF vs MRK: Dividend Comparison 2026

GAILF yields 3.03% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $2.3K in total portfolio value
10 years
GAILF
GAILF
● Live price
3.03%
Share price
$10.75
Annual div
$0.33
5Y div CAGR
11.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.5K
Annual income
$1,212.11
Full GAILF calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — GAILF vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGAILFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GAILF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GAILF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GAILF
Annual income on $10K today (after 15% tax)
$257.28/yr
After 10yr DRIP, annual income (after tax)
$1,030.29/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, GAILF beats the other by $222.55/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GAILF + MRK for your $10,000?

GAILF: 50%MRK: 50%
100% MRK50/50100% GAILF
Portfolio after 10yr
$29.6K
Annual income
$1,081.21/yr
Blended yield
3.65%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

GAILF
No analyst data
Altman Z
2.7
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GAILF buys
0
MRK buys
0
No recent congressional trades found for GAILF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGAILFMRK
Forward yield3.03%3.25%
Annual dividend / share$0.33$3.08
Payout ratio50%42%
1-year div growth0%5.5%
5-year div CAGR11.2%8.2%
Portfolio after 10y$28.5K$30.7K
Annual income after 10y$1,212.11$950.29
Total dividends collected$6.9K$6.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GAILF vs MRK ($10,000, DRIP)

YearGAILF PortfolioGAILF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,037$336.58$11,192$351.54$155.00MRK
2$12,195$386.05$12,524$392.70$329.00MRK
3$13,492$443.32$14,015$438.65$523.00MRK
4$14,946$509.72$15,682$489.96$736.00MRK
5$16,579$586.82$17,547$547.23$968.00MRK
6$18,416$676.49$19,632$611.16$1.2KMRK
7$20,487$780.94$21,963$682.53$1.5KMRK
8$22,823$902.82$24,571$762.18$1.7KMRK
9$25,466$1,045.29$27,486$851.08$2.0KMRK
10$28,461$1,212.11$30,745$950.29$2.3KMRK

GAILF vs MRK: Complete Analysis 2026

GAILFStock

GAIL (India) Limited operates as a natural gas processing and distribution company in India and internationally. The company operates through Transmission Services, Natural Gas Marketing, Petrochemicals, LPG and Other Liquid Hydrocarbons, and Other segments. It is involved in the transmission and marketing of natural gas to the power, fertilizer, industrial, automotive, petrochemicals, and domestic and commercial sectors. It also markets liquefied petroleum gas (LPG), propane, pentane, naphtha, mixed fuel oil, polyethylene, and polypropylene; and manufactures petrochemicals, such as high-density polyethylene and linear low-density polyethylene under the brand names of G-Lex and G-Lene. In addition, the company generates wind and solar power. Further, the company engages in the chartering of LNG vessels. The company owns and operates approximately 14,500 km of natural gas pipeline. Additionally, the company operates 5 gas processing plants, 2 petrochemicals plants, 10 LPG pumping/receiving stations, and 8 natural gas compressor stations. GAIL (India) Limited was incorporated in 1984 and is based in New Delhi, India.

Full GAILF Calculator →

MRKHealthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this GAILF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GAILF vs SCHDGAILF vs JEPIGAILF vs OGAILF vs KOGAILF vs MAINGAILF vs JNJGAILF vs ABBVGAILF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.